X

CTS History

01Aug

Source Plasma Testing

In August CTS begins source plasma testing as a new line of business to one of the largest plasma fractionators in the industry.

About the Author

Related

Research Consortium

CTS Research Consortium was established to further CTS’s leadership in infectious disease research....

Read More >
On-time test results

On-time test results

Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...

Read More >
Pooled Babesia

Pooled Babesia

Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...

Read More >
Babesia

Babesia

In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...

Read More >
CTS implements licensesd Zika test

CTS implements licensesd Zika test

Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...

Read More >
Implementation of a COVID-19 Test

Implementation of a COVID-19 Test

CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...

Read More >